Patents Assigned to Immunowake Inc.
  • Patent number: 11912754
    Abstract: The present application provides an antibody fusion protein comprising a vascular endothelial growth factor receptor (VEGFR) fused to the C-terminus of the antibody light chain. Also provided are methods of making and using these antibody fusion proteins.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: February 27, 2024
    Assignee: IMMUNOWAKE INC.
    Inventor: Xiaoyun Wu
  • Publication number: 20230167164
    Abstract: The present application relates to immunocytokines comprising a cytokine or variant thereof positioned at the hinge region of a heavy chain of an antibody (e.g., full-length antibody), or positioned at a hinge region between an antigen-binding fragment (e.g., ligand, receptor, or antibody fragment) and an Fc domain subunit or portion thereof, methods of making, and uses thereof.
    Type: Application
    Filed: January 19, 2023
    Publication date: June 1, 2023
    Applicant: Immunowake Inc.
    Inventors: Ellen WU, Xiaoyun WU, John WAKEFIELD